Literature DB >> 15542691

Oncogenicity of virulent Marek's disease virus cloned as bacterial artificial chromosomes.

Lawrence Petherbridge1, Andrew C Brown, Susan J Baigent, Ken Howes, Melanie A Sacco, Nikolaus Osterrieder, Venugopal K Nair.   

Abstract

Marek's disease virus (MDV) is an oncogenic alphaherpesvirus that induces T-cell lymphomas in poultry. We report the construction of bacterial artificial chromosome (BAC) clones of the highly oncogenic RB-1B strain by inserting mini-F vector sequences into the U(S)2 locus. MDV reconstituted from two BAC clones induced rapid-onset lymphomas similar to those induced by the wild-type virus. Virus reconstituted from another BAC clone that showed a 7.7-kbp deletion in the internal and terminal unique long repeat regions was nononcogenic, suggesting that the deleted region may be associated with oncogenicity. The generation of the oncogenic BAC clones of MDV is a significant step in unraveling the oncogenic determinants of this virus.

Entities:  

Mesh:

Year:  2004        PMID: 15542691      PMCID: PMC525015          DOI: 10.1128/JVI.78.23.13376-13380.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  7 in total

Review 1.  Cloning of herpesviral genomes as bacterial artificial chromosomes.

Authors:  Heiko Adler; Martin Messerle; Ulrich H Koszinowski
Journal:  Rev Med Virol       Date:  2003 Mar-Apr       Impact factor: 6.989

2.  Differential cytokine responses following Marek's disease virus infection of chickens differing in resistance to Marek's disease.

Authors:  Pete Kaiser; Greg Underwood; Fred Davison
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

3.  Influence of oncogenicity of Marek' disease virus on evaluation of genetic resistance.

Authors:  K A Schat; B W Calnek; J Fabricant; H Abplanalp
Journal:  Poult Sci       Date:  1981-12       Impact factor: 3.352

4.  Reconstitution of Marek's disease virus serotype 1 (MDV-1) from DNA cloned as a bacterial artificial chromosome and characterization of a glycoprotein B-negative MDV-1 mutant.

Authors:  D Schumacher; B K Tischer; W Fuchs; N Osterrieder
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

5.  The RNA subunit of telomerase is encoded by Marek's disease virus.

Authors:  Laëtitia Fragnet; Maria A Blasco; Wolfram Klapper; Denis Rasschaert
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

6.  Characterisation of two highly oncogenic strains of Marek's disease virus.

Authors:  K A Schat; B W Calnek; J Fabricant
Journal:  Avian Pathol       Date:  1982       Impact factor: 3.378

7.  Replication-competent bacterial artificial chromosomes of Marek's disease virus: novel tools for generation of molecularly defined herpesvirus vaccines.

Authors:  Lawrence Petherbridge; Ken Howes; Susan J Baigent; Melanie A Sacco; Simon Evans; Nikolaus Osterrieder; Venugopal Nair
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

  7 in total
  54 in total

1.  The ORF012 gene of Marek's disease virus type 1 produces a spliced transcript and encodes a novel nuclear phosphoprotein essential for virus growth.

Authors:  Timo Schippers; Keith Jarosinski; Nikolaus Osterrieder
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

2.  Marek's disease virus expresses multiple UL44 (gC) variants through mRNA splicing that are all required for efficient horizontal transmission.

Authors:  Keith W Jarosinski; Nikolaus Osterrieder
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

3.  Comparative sequence analysis of a highly oncogenic but horizontal spread-defective clone of Marek's disease virus.

Authors:  Stephen J Spatz; Yuguang Zhao; Lawrence Petherbridge; Lorraine P Smith; Susan J Baigent; Venugopal Nair
Journal:  Virus Genes       Date:  2007-08-25       Impact factor: 2.332

4.  Nuclear localization and dynamic properties of the Marek's disease virus oncogene products Meq and Meq/vIL8.

Authors:  Jonathan M Anobile; Vaithilingaraja Arumugaswami; Danielle Downs; Kirk Czymmek; Mark Parcells; Carl J Schmidt
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

5.  Further analysis of Marek's disease virus horizontal transmission confirms that U(L)44 (gC) and U(L)13 protein kinase activity are essential, while U(S)2 is nonessential.

Authors:  Keith W Jarosinski; Nikolaus Osterrieder
Journal:  J Virol       Date:  2010-05-19       Impact factor: 5.103

6.  Identification of an intercistronic internal ribosome entry site in a Marek's disease virus immediate-early gene.

Authors:  Abdessamad Tahiri-Alaoui; Lorraine P Smith; Suzan Baigent; Lydia Kgosana; Lawrence J Petherbridge; Luke S Lambeth; William James; Venugopal Nair
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

7.  Viral control of vTR expression is critical for efficient formation and dissemination of lymphoma induced by Marek's disease virus (MDV).

Authors:  Najat Chbab; Annemarie Egerer; Inês Veiga; Keith W Jarosinski; Nikolaus Osterrieder
Journal:  Vet Res       Date:  2010-04-29       Impact factor: 3.683

8.  A direct comparison of strategies for combinatorial RNA interference.

Authors:  Luke S Lambeth; Nick J Van Hateren; Stuart A Wilson; Venugopal Nair
Journal:  BMC Mol Biol       Date:  2010-10-11       Impact factor: 2.946

9.  Herpesvirus telomerase RNA(vTR)-dependent lymphoma formation does not require interaction of vTR with telomerase reverse transcriptase (TERT).

Authors:  Benedikt B Kaufer; Sascha Trapp; Keith W Jarosinski; Nikolaus Osterrieder
Journal:  PLoS Pathog       Date:  2010-08-26       Impact factor: 6.823

10.  The Marek's disease virus (MDV) protein encoded by the UL17 ortholog is essential for virus growth.

Authors:  Najat Chbab; Danièle Chabanne-Vautherot; Annick Francineau; Nikolaus Osterrieder; Caroline Denesvre; Jean-François Vautherot
Journal:  Vet Res       Date:  2009-03-14       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.